世界の代謝異常症治療薬市場2021年ー2027年:投与経路別(経口、非経口、その他)、疾患別、治療タイプ別、地域別

◆英語タイトル:Global Metabolic Disorder Therapeutics Market Size study, by Route of Administration (Oral, Parenteral and Others), by Disease (Diabetes, Lysosomal Disorders, Obesity and Others), by Therapy Type (Enzyme Replacement Therapy, Cellular Transplantation and Others), and Regional Forecasts 2021-2027
◆商品コード:BZW21UJ066
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2021年6月11日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:米国、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥712,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Bizwit Research社は、2020年におよそ601.6億ドルであった世界の代謝異常症治療薬市場規模が、2021年から2027年の間に7.30%以上の健全な成長率で成長すると予測しています。本調査資料では、代謝異常症治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、疾患別(リソソーム障害、糖尿病、肥満、先天性代謝異常症、高コレステロール血症)分析、投与経路別(経口、非経口、その他)分析、治療タイプ別(酵素補充療法、細胞移植、小分子ベース療法、基質減少療法、遺伝子治療)分析、地域別分析、競争状況、調査プロセスなど、以下の項目を掲載しています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界の代謝異常症治療薬市場規模:疾患別(リソソーム障害、糖尿病、肥満、先天性代謝異常症、高コレステロール血症)
・世界の代謝異常症治療薬市場規模:投与経路別(経口、非経口、その他)
・世界の代謝異常症治療薬市場規模:治療タイプ別(酵素補充療法、細胞移植、小分子ベース療法、基質減少療法、遺伝子治療)
・世界の代謝異常症治療薬市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Metabolic Disorder Therapeutics Market is valued approximately USD 60.16 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 7.30% over the forecast period 2021-2027. Metabolic disorder occurs when abnormal chemical reactions in the body disrupt the process of making energy from the digested food. The rising awareness for the treatment of metabolic disorders and the new research and technological advancements are propelling the Metabolic Disorder Therapeutics market. The rising incidences of various metabolic disorders, especially obesity and diabetes, are also driving the Metabolic Disorder Therapeutics market. According to World Health Organization, an estimated 1.5 million deaths were directly caused by diabetes globally in 2019. Another 2.2 million deaths were attributable to high blood glucose in 2012. In 2019, International Diabetes Federation reports that approximately 463 million adults (20-79 years) were living with diabetes which will rise to 700 million in 2045. Proportion of people with type 2 diabetes is increasing in most countries, with 79% of adults with diabetes living in low- and middle-income countries. More than 1.1 million children and adolescents are living with type 1 diabetes worldwide. The expensive nature of some therapies for rare diseases as well as lack of unequivocal regulatory policies may act as a restraint for its growth. However, increasing awareness for harmful effects of obesity and importance of good metabolism after COVID-19 pandemic acts as an opportunity for Metabolic Disorder Therapeutics Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Metabolic Disorder Therapeutics Market. Due to higher expenditure on healthcare as well as higher per capita income, North America has emerged as the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit the highest growth rate for the forecast period 2021-2027 owing to the rising disposable income and growing incidences of diabetes and obesity along with other metabolic disorders in the region.

Major market player included in this report are:
Novo Nordisk
Eli Lilly and Company
Shire Plc
Sanofi
Merck KGaA
AstraZeneca
AbbVie Inc.,
Actelion Pharmaceuticals Ltd
Amgen Inc.,
Biocon

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease:
Lysosomal Storage Diseases
Diabetes
Obesity
Inherited Metabolic Disorders
Hypercholesterolemia

By Route of Administration:
Oral Administration
Parenteral Administration
Other route of administration

By Therapy Type:
Enzyme Replacement Therapy
Cellular Transplantation
Small Molecule-Based Therapy
Substrate Reduction Therapy
Gene Therapy
Drug Therapy

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Metabolic Disorder Therapeutics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1.Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Metabolic Disorder Therapeutics Market, by Disease, 2019-2027 (USD Billion)
1.2.2. Metabolic Disorder Therapeutics Market, by Route of Administration, 2019-2027 (USD Billion)
1.2.3. Metabolic Disorder Therapeutics Market, by Therapy Type, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Metabolic Disorder Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Metabolic Disorder Therapeutics Market Dynamics
3.1. Metabolic Disorder Therapeutics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of diabetes and obesity
3.1.1.2. Research and development in the field therapy
3.1.2. Market Challenges
3.1.2.1. High cost of treatment of rare diseases
3.1.3. Market Opportunities
3.1.3.1. Increased expenditure from government and international bodies
Chapter 4. Global Metabolic Disorder Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Metabolic Disorder Therapeutics Market, by Disease
5.1. Market Snapshot
5.2. Global Metabolic Disorder Therapeutics Market by Disease, Performance – Potential Analysis
5.3. Global Metabolic Disorder Therapeutics Market Estimates & Forecasts by Disease 2018-2027 (USD Billion)
5.4. Metabolic Disorder Therapeutics Market, Sub Segment Analysis
5.4.1. Lysosomal Storage Diseases
5.4.2. Diabetes
5.4.3. Obesity
5.4.4. Inherited Metabolic Disorders
5.4.5. Hypercholesterolemia
Chapter 6. Global Metabolic Disorder Therapeutics Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Metabolic Disorder Therapeutics Market by Route of Administration, Performance – Potential Analysis
6.3. Global Metabolic Disorder Therapeutics Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
6.4. Metabolic Disorder Therapeutics Market, Sub Segment Analysis
6.4.1. Oral Administration
6.4.2. Parenteral Administration
6.4.3. Other route of administration
Chapter 7. Global Metabolic Disorder Therapeutics Market, by Therapy Type
7.1. Market Snapshot
7.2. Global Metabolic Disorder Therapeutics Market by Therapy Type, Performance – Potential Analysis
7.3. Global Metabolic Disorder Therapeutics Market Estimates & Forecasts by Therapy Type 2018-2027 (USD Billion)
7.4. Metabolic Disorder Therapeutics Market, Sub Segment Analysis
7.4.1. Enzyme Replacement Therapy
7.4.2. Cellular Transplantation
7.4.3. Small Molecule-Based Therapy
7.4.4. Substrate Reduction Therapy
7.4.5. Gene Therapy
7.4.6. Drug Therapy
Chapter 8. Global Metabolic Disorder Therapeutics Market, Regional Analysis
8.1. Metabolic Disorder Therapeutics Market, Regional Market Snapshot
8.2. North America Metabolic Disorder Therapeutics Market
8.2.1. U.S. Metabolic Disorder Therapeutics Market
8.2.1.1. Disease breakdown estimates & forecasts, 2018-2027
8.2.1.2. Route of Administration breakdown estimates & forecasts, 2018-2027
8.2.1.3. Therapy Type breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Metabolic Disorder Therapeutics Market
8.3. Europe Metabolic Disorder Therapeutics Market Snapshot
8.3.1. U.K. Metabolic Disorder Therapeutics Market
8.3.2. Germany Metabolic Disorder Therapeutics Market
8.3.3. France Metabolic Disorder Therapeutics Market
8.3.4. Spain Metabolic Disorder Therapeutics Market
8.3.5. Italy Metabolic Disorder Therapeutics Market
8.3.6. Rest of Europe Metabolic Disorder Therapeutics Market
8.4. Asia-Pacific Metabolic Disorder Therapeutics Market Snapshot
8.4.1. China Metabolic Disorder Therapeutics Market
8.4.2. India Metabolic Disorder Therapeutics Market
8.4.3. Japan Metabolic Disorder Therapeutics Market
8.4.4. Australia Metabolic Disorder Therapeutics Market
8.4.5. South Korea Metabolic Disorder Therapeutics Market
8.4.6. Rest of Asia Pacific Metabolic Disorder Therapeutics Market
8.5. Latin America Metabolic Disorder Therapeutics Market Snapshot
8.5.1. Brazil Metabolic Disorder Therapeutics Market
8.5.2. Mexico Metabolic Disorder Therapeutics Market
8.6. Rest of The World Metabolic Disorder Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.3. Novo Nordisk
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Eli Lilly and Company
9.3.3. Shire Plc
9.3.4. Sanofi
9.3.5. Merck KGaA
9.3.6. AstraZeneca
9.3.7. AbbVie Inc.,
9.3.8. Actelion Pharmaceuticals Ltd
9.3.9. Amgen Inc.,
9.3.10. Biocon
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Metabolic Disorder Therapeutics Market, report scope
TABLE 2. Global Metabolic Disorder Therapeutics Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Metabolic Disorder Therapeutics Market estimates & forecasts by Disease 2018-2027 (USD Billion)
TABLE 4. Global Metabolic Disorder Therapeutics Market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
TABLE 5. Global Metabolic Disorder Therapeutics Market estimates & forecasts by Therapy Type 2018-2027 (USD Billion)
TABLE 6. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Metabolic Disorder Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Metabolic Disorder Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. U.S. Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. U.S. Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 18. U.S. Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 19. Canada Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Canada Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 21. Canada Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 22. UK Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. UK Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. UK Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Germany Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Germany Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Germany Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. RoE Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. RoE Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. RoE Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. China Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. China Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. China Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. India Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. India Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. India Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Japan Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Japan Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Japan Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. RoAPAC Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. RoAPAC Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. RoAPAC Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. Brazil Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. Brazil Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. Brazil Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. Mexico Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. Mexico Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. Mexico Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. RoLA Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. RoLA Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. RoLA Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Row Metabolic Disorder Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Row Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Row Metabolic Disorder Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Metabolic Disorder Therapeutics Market
TABLE 56. List of primary sources, used in the study of global Metabolic Disorder Therapeutics Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered


List of figures
FIG 1. Global Metabolic Disorder Therapeutics Market, research methodology
FIG 2. Global Metabolic Disorder Therapeutics Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Metabolic Disorder Therapeutics Market, key trends 2020
FIG 5. Global Metabolic Disorder Therapeutics Market, growth prospects 2021-2027
FIG 6. Global Metabolic Disorder Therapeutics Market, porters 5 force model
FIG 7. Global Metabolic Disorder Therapeutics Market, pest analysis
FIG 8. Global Metabolic Disorder Therapeutics Market, value chain analysis
FIG 9. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Metabolic Disorder Therapeutics Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Metabolic Disorder Therapeutics Market, regional snapshot 2018 & 2027
FIG 15. North America Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
FIG 16. Europe Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
FIG 17. Asia pacific Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
FIG 18. Latin America Metabolic Disorder Therapeutics Market 2018 & 2027 (USD Billion)
FIG 19. Global Metabolic Disorder Therapeutics Market, company market share analysis (2020)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の代謝異常症治療薬市場2021年ー2027年:投与経路別(経口、非経口、その他)、疾患別、治療タイプ別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆